Global Blood Therapeutics (GBT) Misses Q4 EPS by 23c

February 23, 2022 5:06 PM EST

Global Blood Therapeutics (NASDAQ: GBT) reported Q4 EPS of ($1.36), $0.23 worse than the analyst estimate of ($1.13). Revenue for the quarter came in at $56.1 million versus the consensus estimate of $55.44 million.

For earnings history and earnings-related data on Global Blood Therapeutics (GBT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings